Life Biosciences plans to begin human clinical trials of a cellular rejuvenation therapy in optic neuropathies after receiving FDA clearance of an investigational new drug application, according to a press release.ER-100 aims to modify the epigenome of cells to restore injured cells without changing their underlying DNA sequence, according to the release.“For eye care … [Read more...] about FDA clears investigational new drug application for ER-100
News
Retaine Omega Forté omega-3 dry eye supplement launches
Retaine Omega Forté, an omega-3 nutritional supplement aimed at alleviating symptoms of dry eye, is now available, according to a press release from OcuSoft.Retaine Omega Forté is intended for any patient with dry eye or meibomian gland dysfunction as well as “patients who take omega-3 for other health benefits because of its potency,” George Haines, executive vice president of … [Read more...] about Retaine Omega Forté omega-3 dry eye supplement launches
Week in Review: Physical Activity and Glaucoma Risk, Language Concordance Between Ophthalmologists and Patients
Glaucoma risk may not be reduced with increased physical activity, and there are gaps in language concordance between US ophthalmologists and the populations they serve. … [Read more...] about Week in Review: Physical Activity and Glaucoma Risk, Language Concordance Between Ophthalmologists and Patients
FDA approves readministration of iDose TR
Editor’s note: This is a developing news story. Please check back soon for updates.The FDA approved a new drug application labeling supplement that allows readministration of iDose TR with a repeat treatment protocol, according to a press release from Glaukos.With the updated labeling, iDose TR (travoprost intracameral implant) may be readministered more than once in patients … [Read more...] about FDA approves readministration of iDose TR
Burdensome health care cost pervasive in U.S.
Burdensome health care spending in the United States is a wide-reaching issue that requires multiple solutions, according to an expert.Adam Gaffney, MD, MPH, an assistant professor of medicine at Harvard Medical School, and colleagues recently published the results of a cohort study evaluating burdensome health care spending over time among individuals in the U.S.The study, … [Read more...] about Burdensome health care cost pervasive in U.S.